PPT-Diabetes research update:

GGC MCN meeting 5 th February 2019 John R Petrie Professor of Diabetic Medicine University of Glasgow UK Advisory and Consultancy Work Novo Nordisk SanofiAventis Biocon Astra Zeneca Servier. People with diabetes have high blood glucose also called high blood sugar or hyperglycemia Diabetes is a disorder of metabolism the way the body uses digested food for energy The digestive tract breaks down carbohydratessugars and starches found in Agenda. Evolution of Diabetes Prevention. Program Overview & Consumer Experience. Engagement Results . What . Makes Real Appeal Different. 2. Real Learnings. Partnership . between UnitedHealth Group and the YMCA proves DPP research can be brought to the community at acceptable cost. Dr Gill Hood. North Thames Clinical Research Network. Barts Health NHS Trust. 18.7.14. Host. NIHR Clinical Research Network name. Barts. Health NHS Trust. North Thames. Central Manchester University Hospitals NHS Foundation Trust. Population Health and Health Services Research Alliance Seminar . 28. th. April 2015. Jenny Mc Sharry & Molly Byrne. Health Behaviour Change Research Group, NUI Galway. Systematic reviews Qualitative research Theory buildin. Professor John Chambers . BA, MBBS, FRCP, PhD. Imperial College London, UK. LKC School of Medicine, Singapore. Clinician and a Scientist … . South Asians ~50% of local population. Compared to Europeans, increased. Yshay. . Shlesinger. , MD. NorCal. Endocrinology & Internal Medicine. 111 Deerwood Rd Suite 180 San Ramon CA 94583. 729 Sunrise Ave Suite 501 Roseville CA 95661. 1. Development of Type 2 Diabetes Depends on Interplay Between Insulin Resistance and . November 2008 Hu He KH, Brun T, Thorel F, Aeberhard D, Duhamel D, Brighouse D, Herrera P, Meda P, Gauthier BR. Conditional overexpression of the transcription factor Pax4 in pancreatic islet beta-ce Research advances like arti31cial pancreas systemsmove us towards a day where kids like Ryan won146t have to wake up during the night to drink juice The research behind cell replacementpatients like N some. . of . B. ioactive Adamantane . F. ragment . C. ontaining . N. ew . P. eptides . V. ia Ugi- . R. eaction. Ugi reaction.  . Ugi . reaction mechanism. AGENT. THERAOEUTICAL USE. Potential peptide and protein drug. Presented by Deborah . Taira. , ScD. RTRN Research Coordinating Center. University of Hawaii. A Summary of Two Funding Opportunity Announcements (FOAs). Translational Research to Improve Diabetes and Obesity Outcomes (R01). Basal-Bolus Insulin Therapy (BBIT). Tammy McNab MD FRCP(C). Objectives. To overview the current initiative to implement BBIT. To discuss caveats to insulin use. . as it impacts BBIT and perioperative glycemic control. October 24, 2013. Concepcion R. Nierras, Ph.D.. Assistant Vice President, International Partnerships, JDRF. JDRF Mission. Largest charitable supporter of T1D research in the world: USD 1.7 Billion invested in research over 40+ years. Purpose of this meeting. What is nursing & nursing research. Order of presentations. SoN Faculty, SPHIS Faculty & Collaboration Targets. Deliverables. Valerie, Virginia, Lee, Sandra, Carlee, Diane, Said & Peggy. Background. Method. Results. Abstract. Acknowledgements: . My line Manager Claire Wesselingh for supporting me to apply to this internship programme and affording me the time to work on my research as well as the wider diabetes & dietetic departments at Mersey and West Lancashire Teaching Hospitals NHS Trust .